YIH
SYRS

Y-Intercept (HK)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Y-Intercept (HK)’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,463
Closed -$98.8K – 2028
2024
Q1 		$98.8K Buy
18,463
+7,951
+76% +$42.5K 0.01% 1282
2023
Q4 		$81.9K Buy
+10,512
New +$81.9K 0.01% 1126
2022
Q3 		– Sell
-1,013
Closed -$10K – 1336
2022
Q2 		$10K Buy
+1,013
New +$10K ﹤0.01% 815